Stock Events

Stock Events

Myomo 

$0.68
0
-$0.02-3.49% Wednesday 07:56

Statistics

Day High
0.68
Day Low
0.64
52W High
-
52W Low
-
Volume
50
Avg. Volume
-
Mkt Cap
25.97M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2025
Q4 2025
Next
-0.11
-0.1
-0.1
-0.09
Expected EPS
-0.114
Actual EPS
N/A

Financials

-19%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
65.1MRevenue
-12.37MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MYO.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Ekso Bionics
EKSO
Mkt Cap14.14M
Ekso Bionics designs and manufactures powered exoskeletons which can be used for rehabilitation and mobility, directly competing with Myomo's mobility enhancement devices.
Resmed
RMD
Mkt Cap36.04B
ResMed is known for its products in the sleep and respiratory markets but also offers devices that can improve quality of life, indirectly competing with Myomo's focus on enhancing mobility.
Hologic
HOLX
Mkt Cap16.45B
Hologic, primarily focused on women's health, also develops medical devices that can compete indirectly with Myomo by offering diagnostic and treatment solutions in overlapping healthcare markets.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew specializes in orthopedics, including robotics and digital solutions for surgery, which can indirectly compete with Myomo's orthotic devices by offering alternative treatments and rehabilitation methods.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare, including products for joint reconstruction which can indirectly compete with Myomo's solutions for mobility and rehabilitation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc offers a wide range of medical devices and therapies, including those for spinal and musculoskeletal conditions, indirectly competing with Myomo's assistive technologies.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical and surgical equipment, including neurotechnology and spine products, which can indirectly compete with Myomo's focus on enhancing mobility through technology.
Globus Medical
GMED
Mkt Cap8.16B
Globus Medical, Inc. focuses on musculoskeletal solutions, including innovative spine and orthopedic devices, indirectly competing with Myomo by offering alternative treatments for mobility impairments.

About

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Show more...
CEO
ISIN
US62857J2015

Listings

F
DE
0M61.F
XASE
US
MYO
BOATS
BOATS
MYO.BOATS

0 Comments

Share your thoughts

FAQ

What is Myomo stock price today?▼
The current price of MYO.BOATS is $0.68 USD — it has decreased by -3.49% in the past 24 hours. Watch Myomo stock price performance more closely on the chart.
What is Myomo stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Myomo stocks are traded under the ticker MYO.BOATS.
What is Myomo market cap?▼
Today Myomo has the market capitalization of 25.97M
When is the next Myomo earnings date?▼
Myomo is going to release the next earnings report on May 13, 2026.
What were Myomo earnings last quarter?▼
MYO.BOATS earnings for the last quarter are -0.09 USD per share, whereas the estimation was -0.09 USD resulting in a -4.65% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Myomo revenue for the last year?▼
Myomo revenue for the last year amounts to 65.1M USD.
What is Myomo net income for the last year?▼
MYO.BOATS net income for the last year is -12.37M USD.
When did Myomo complete a stock split?▼
Myomo has not had any recent stock splits.